4.7 Article

A new hybrid method based on local fisher discriminant analysis and support vector machines for hepatitis disease diagnosis

Journal

EXPERT SYSTEMS WITH APPLICATIONS
Volume 38, Issue 9, Pages 11796-11803

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.eswa.2011.03.066

Keywords

Hepatitis disease diagnosis; Local fisher discriminant analysis; Support vector machines; Feature extraction

Funding

  1. National Natural Science Foundation of China (NSFC) [60873149, 60973088, 60773099]
  2. National High-Tech Research and Development Plan of China [2006AA10Z245, 2006AA10A309]
  3. Shanghai Key Laboratory of Intelligent Information Processing in Fudan University [IIPL-09-007]
  4. National Laboratory of Pattern Recognition (NLPR)
  5. Chinese Ministry of Education

Ask authors/readers for more resources

In this paper, a novel hybrid method named the LFDA_SVM, which integrates a new feature extraction method and a classification algorithm, has been introduced for diagnosing hepatitis disease. The two integrated methods are the local fisher discriminant analysis (LFDA) and the supporting vector machine (SVM), respectively. In the proposed LFDA_SVM, the LFDA is employed as a feature extraction tool for dimensionality reduction in order to further improve the diagnostic accuracy of the standard SVM algorithm. The effectiveness of the LFDA_SVM has been rigorously evaluated against the hepatitis dataset, a benchmark dataset, from UCI Machine Learning Database in terms of classification accuracy, sensitivity and specificity respectively. In addition, the proposed LFDA_SVM has been compared with three existing methods including the SVM based on principle component analysis (PCA_SVM), the SVM based on fisher discriminant analysis (FDA_SVM) and the standard SVM in terms of their classification accuracy. Experimental results have demonstrated that the LFDA_SVM greatly outperforms other three methods. The best classification accuracy (96.77%) obtained by the LFDA_SVM is much higher than that of the compared ones. Promisingly, the proposed LFDA_SVM might serve as a new candidate of powerful methods for diagnosing hepatitis with excellent performance. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available